Transcend Capital Advisors, LLC Pfizer Inc Transaction History

Transcend Capital Advisors, LLC

$1.29 Billion
Q2 2025

A detailed history of Transcend Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 57,536 shares of PFE stock, worth $1.42 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

57,536

Previous 123,586 53.44%

Holding current value

$1.42 Million

Previous $3.13 Million 55.48%

% of portfolio

0.11%

Previous 0.23%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	SELL	$21.59 - $24.84 $1.43 Million - $1.64 Million	-66,050 Reduced 53.44%	57,536 $1.39 Million
Q1 2025 Apr 24, 2025	SELL	$25.01 - $27.13 $707,357 - $767,317	-28,283 Reduced 18.62%	123,586 $3.13 Million
Q4 2024 Feb 03, 2025	SELL	$24.8 - $30.19 $201,252 - $244,991	-8,115 Reduced 5.07%	151,869 $4.03 Million
Q3 2024 Oct 15, 2024	BUY	$27.7 - $31.39 $144,483 - $163,730	5,216 Added 3.37%	159,984 $4.63 Million
Q2 2024 Jul 02, 2024	BUY	$25.26 - $29.6 $31,448 - $36,852	1,245 Added 0.81%	154,768 $4.33 Million
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $834,848 - $958,673	32,246 Added 26.59%	153,523 $4.26 Million
Q4 2023 Feb 05, 2024	BUY	$26.13 - $33.94 $1.52 Million - $1.97 Million	57,988 Added 91.62%	121,277 $3.49 Million
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $197,578 - $230,949	-6,157 Reduced 8.87%	63,289 $2.1 Million
Q2 2023 Jul 13, 2023	BUY	$36.12 - $41.79 $66,244 - $76,642	1,834 Added 2.71%	69,446 $2.55 Million
Q1 2023 Apr 12, 2023	SELL	$39.39 - $51.28 $73,698 - $95,944	-1,871 Reduced 2.69%	67,612 $2.76 Million
Q4 2022 Jan 20, 2023	SELL	$41.75 - $54.5 $258,683 - $337,682	-6,196 Reduced 8.19%	69,483 $0
Q3 2022 Oct 17, 2022	SELL	$43.76 - $53.42 $46,516 - $56,785	-1,063 Reduced 1.39%	75,679 $3.31 Million
Q2 2022 Jul 12, 2022	BUY	$46.53 - $55.17 $22,799 - $27,033	490 Added 0.64%	76,742 $4.02 Million
Q1 2022 Apr 20, 2022	BUY	$45.75 - $56.69 $277,290 - $343,598	6,061 Added 8.64%	76,252 $3.95 Million
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $84,210 - $124,827	2,038 Added 2.99%	70,191 $4.15 Million
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $24,649 - $31,663	628 Added 0.93%	68,153 $2.97 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $145,327 - $164,631	4,047 Added 6.38%	67,525 $2.65 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $25,050 - $28,251	748 Added 1.19%	63,478 $2.3 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $1.54 Million - $1.96 Million	-45,958 Reduced 42.28%	62,730 $2.31 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $836,549 - $981,463	26,348 Added 32.0%	108,688 $3.99 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $218,129 - $264,622	-7,242 Reduced 8.08%	82,340 $2.69 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $20,002 - $28,578	740 Added 0.83%	89,582 $2.93 Million
Q4 2019 Feb 19, 2020	BUY	$32.92 - $37.36 $2.92 Million - $3.32 Million	88,842 New	88,842 $3.48 Million

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Account

Transcend Capital Advisors, LLC Pfizer Inc Transaction History